1. Home
  2. HMY vs LNTH Comparison

HMY vs LNTH Comparison

Compare HMY & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Gold Mining Company Limited

HMY

Harmony Gold Mining Company Limited

HOLD

Current Price

$18.80

Market Cap

10.3B

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$99.99

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMY
LNTH
Founded
1950
1956
Country
South Africa
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
6.6B
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
HMY
LNTH
Price
$18.80
$99.99
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$16.00
$87.00
AVG Volume (30 Days)
3.7M
922.1K
Earning Date
02-04-2016
05-07-2026
Dividend Yield
2.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.91
Revenue
N/A
$343,374,000.00
Revenue This Year
$37.43
N/A
Revenue Next Year
$27.44
$14.19
P/E Ratio
$15.60
$34.36
Revenue Growth
N/A
3.62
52 Week Low
$13.03
$49.67
52 Week High
$26.04
$111.86

Technical Indicators

Market Signals
Indicator
HMY
LNTH
Relative Strength Index (RSI) N/A 40.87
Support Level N/A $99.92
Resistance Level N/A $101.43
Average True Range (ATR) 0.00 0.44
MACD 0.00 0.01
Stochastic Oscillator 0.00 0.93

Price Performance

Historical Comparison
HMY
LNTH

About HMY Harmony Gold Mining Company Limited

Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: